查找临床试验
已按「原发性胆汁性胆管炎」检索，对应国际通用词 primary biliary cholangitis
共找到 13 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
China
年龄 18 Years – 75 Years
Cascade Pharmaceuticals, Inc
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
China
年龄 18 Years – 75 Years
Xijing Hospital of Digestive Diseases
Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
China
年龄 18 Years – 70 Years
Xijing Hospital of Digestive Diseases
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
China
年龄 18 Years – 75 Years
Xijing Hospital of Digestive Diseases
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 75 Years
Ipsen
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 不限
Gilead Sciences
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
China
年龄 18 Years – 75 Years
Xijing Hospital of Digestive Diseases
Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
China
年龄 18 Years – 不限
Peking Union Medical College Hospital
PBC Long-term Outcomes Study
China
年龄 不限 – 不限
Beijing Friendship Hospital
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
China
年龄 18 Years – 75 Years
Xijing Hospital of Digestive Diseases
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
China
年龄 18 Years – 75 Years
Xijing Hospital of Digestive Diseases
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
China
年龄 18 Years – 75 Years
Xijing Hospital of Digestive Diseases